Wellington Management CEO Jean Hynes joins Morgan Stanley’s Amy Ellis for a candid look at the pivotal investment calls that defined her career in biotech—one that delivered outsized long term value, and one that tested her conviction when the stock fell 90% overnight. From navigating patent cliffs to dissecting drug pipelines, Hynes shares what it really takes to separate the signal from the noise in one of the most complex corners of the market. She also reflects on the leadership lessons that guided her path to CEO and how she’s positioning Wellington for the future. Watch the full episode and save the Hard Lessons playlist for more pivotal choices from iconic investors.

 6305      87